Unknown

Dataset Information

0

Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP).


ABSTRACT: The cytokine interleukin 1(IL-1) initiates a wide range of proinflammatory cascades and its inhibition has been shown to decrease inflammation in a variety of diseases. IL-1 receptor accessory protein (IL-1RAcP) is an indispensible part of the IL-1R complex that stabilizes IL-1/IL-1R interaction and plays an important role in the signal transduction of the receptor complex. The soluble form of IL-1RAcP (sIL-1RAcP) contains only the extracellular domain and serves as a natural inhibitor of IL-1 signaling. Therefore, increasing sIL-1RAcP levels might be an attractive therapeutic strategy to inhibit IL-1-driven inflammation. To achieve this we designed specific antisense oligonucleotides (AON), to redirect pre-mRNA IL-1RAcP splicing by skipping of the transmembrane domain encoding exon 9. This would give rise to a novel ?9IL-1RAcP mRNA encoding a soluble, secreted form of IL-1RAcP, which might have similar activity as natural sIL-1RAcP. AON treatment resulted in exon 9 skipping both in vitro and in vivo. A single dose injection of 10?mg AON/kg body weight induced 90% skipping in mouse liver during at least 5 days. The truncated mRNA encoded for a secreted, soluble ?9IL-1RAcP protein. IL-1RAcP skipping resulted in a substantial inhibition of IL-1 signaling in vitro. These results indicate that skipping of the transmembrane encoding exon 9 of IL-1RAcP using specific AONs might be a promising therapeutic strategy in a variety of chronic inflammatory diseases.Molecular Therapy - Nucleic Acids (2013) 2, e66; doi:10.1038/mtna.2012.58; published online 22 January 2013.

SUBMITTER: Y?lmaz-Elis AS 

PROVIDER: S-EPMC3564974 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP).

Yılmaz-Eliş A Seda AS   Aartsma-Rus Annemieke A   't Hoen Peter Ac PA   Safdar Huma H   Breukel Cor C   van Vlijmen Bart Jm BJ   van Deutekom Judith J   de Kimpe Sjef S   van Ommen Gert-Jan GJ   Verbeek J Sjef JS  

Molecular therapy. Nucleic acids 20130122


The cytokine interleukin 1(IL-1) initiates a wide range of proinflammatory cascades and its inhibition has been shown to decrease inflammation in a variety of diseases. IL-1 receptor accessory protein (IL-1RAcP) is an indispensible part of the IL-1R complex that stabilizes IL-1/IL-1R interaction and plays an important role in the signal transduction of the receptor complex. The soluble form of IL-1RAcP (sIL-1RAcP) contains only the extracellular domain and serves as a natural inhibitor of IL-1 s  ...[more]

Similar Datasets

| S-EPMC4701541 | biostudies-literature
| S-EPMC8037683 | biostudies-literature
| S-EPMC4811139 | biostudies-literature
| S-EPMC8355726 | biostudies-literature
| S-EPMC6465270 | biostudies-literature
| S-EPMC5059676 | biostudies-literature
| S-EPMC10481881 | biostudies-literature
| S-EPMC1933433 | biostudies-literature
| S-EPMC7590164 | biostudies-literature
| S-EPMC3637291 | biostudies-literature